Xia Kaide, Jin Shuai, Chen Guifang, Zhang Haiwang, Zhang Qiao
Guiyang Maternal and Child Health Care Hospital, Guiyang Children's Hospital, Guiyang, China.
School of Biology and Engineering (School of Health Medicine Modern Industry), Guizhou Medical University, Guiyang, China.
Front Nutr. 2025 Mar 24;12:1544582. doi: 10.3389/fnut.2025.1544582. eCollection 2025.
Metabolic syndrome (MS) is a complex metabolic disorder that is often closely associated with the development of chronic diseases such as cardiovascular disease and diabetes. This study aimed to explore the relationship between estimated glucose metabolic rate (eGDR) and MS. The correlation between eGDR levels and the prevalence of metabolic syndrome was analyzed here based on data from the National Health and Nutrition Examination Survey from 2005 to 2020. The study sample consisted of 63,131 adult participants, and the results showed that lower eGDR levels were significantly associated with a higher prevalence of metabolic syndrome. Further regression analyses showed that eGDR acted as a protective factor and that the risk of MS significantly decreased as its level increased. Subgroup analyses showed that this trend held across gender, age, and BMI categories, and that the protective effect of eGDR was weaker in the higher BMI group. Based on the nonlinear relationship between subjects' eGDR levels and MS prevalence, RCS analyses further confirmed a significant correlation between lower eGDR levels and increased risk of MS. In conclusion, the present study suggests that eGDR levels could serve as a potential biomarker for predicting metabolic syndrome, providing new perspectives for early screening and intervention of MS.
代谢综合征(MS)是一种复杂的代谢紊乱疾病,常与心血管疾病和糖尿病等慢性疾病的发生密切相关。本研究旨在探讨估计葡萄糖代谢率(eGDR)与MS之间的关系。基于2005年至2020年美国国家健康与营养检查调查的数据,分析了eGDR水平与代谢综合征患病率之间的相关性。研究样本包括63131名成年参与者,结果显示较低的eGDR水平与较高的代谢综合征患病率显著相关。进一步的回归分析表明,eGDR起到保护作用,随着其水平升高,MS风险显著降低。亚组分析表明,这种趋势在性别、年龄和BMI类别中均成立,且在较高BMI组中eGDR的保护作用较弱。基于受试者eGDR水平与MS患病率之间的非线性关系,限制立方样条(RCS)分析进一步证实较低的eGDR水平与MS风险增加之间存在显著相关性。总之,本研究表明eGDR水平可作为预测代谢综合征的潜在生物标志物,为MS的早期筛查和干预提供了新的视角。